Announcement • Jun 17
GMO Product Platform, Inc. to Report Q2, 2026 Results on Aug 13, 2026 GMO Product Platform, Inc. announced that they will report Q2, 2026 results on Aug 13, 2026 Reported Earnings • May 13
First quarter 2026 earnings released: EPS: JP¥43.61 (vs JP¥41.01 loss in 1Q 2025) First quarter 2026 results: EPS: JP¥43.61 (up from JP¥41.01 loss in 1Q 2025). Revenue: JP¥2.00b (up 52% from 1Q 2025). Net income: JP¥192.0m (up JP¥259.0m from 1Q 2025). Profit margin: 9.6% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to JP¥1,706, the stock trades at a trailing P/E ratio of 48.5x. Average trailing P/E is 16x in the Media industry in Japan. Total loss to shareholders of 38% over the past three years. New Risk • Feb 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (5.5% average weekly change). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥8.10b market cap, or US$52.8m). Reported Earnings • Feb 11
Full year 2025 earnings released: EPS: JP¥41.66 (vs JP¥112 in FY 2024) Full year 2025 results: EPS: JP¥41.66 (down from JP¥112 in FY 2024). Revenue: JP¥6.82b (up 36% from FY 2024). Net income: JP¥155.0m (down 15% from FY 2024). Profit margin: 2.3% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. New Risk • Feb 11
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.3% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (170% increase in shares outstanding). Minor Risks Dividend is not well covered by earnings (158% payout ratio). Profit margins are more than 30% lower than last year (2.3% net profit margin). Market cap is less than US$100m (JP¥9.03b market cap, or US$59.0m). Announcement • Feb 10
GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026 GMO Product Platform, Inc., Annual General Meeting, Mar 17, 2026. Announcement • Dec 27
GMO Product Platform, Inc. to Report Fiscal Year 2025 Results on Feb 10, 2026 GMO Product Platform, Inc. announced that they will report fiscal year 2025 results on Feb 10, 2026 Upcoming Dividend • Dec 22
Upcoming dividend of JP¥34.58 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 23 March 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.6%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (1.7%). Announcement • Dec 17
GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million. GMO Product Platform, Inc. (TSE:3695) agreed to acquire 53.60% stake in STOCK POINT Inc. from Credit Saison Co., Ltd. (TSE:8253), KITS Co., Ltd and Kiyomi Tsuchiya for approximately ¥360 million on December 15, 2025. A cash consideration of ¥361 million will be paid by GMO Product Platform, Inc. The scheduled contract execution date is December 16, 2025. Prior to the share transfer execution date, we may acquire additional shares of STOCK POINT Inc. held by other individuals and corporations. In this case, the maximum acquisition price will be ¥564 million, and the maximum number of shares to be acquired will be 1,324 shares and the maximum ownership ratio will be 82.5%. Additional disclosure is planned once the acquisition price and number of shares for the additional acquisition are finalized.
For the period ending March 31, 2025, STOCK POINT Inc. reported total revenue of ¥374.18 million, operating loss of ¥231.81 million and net income of ¥200.21 million. As of March 31, 2025, STOCK POINT Inc. reported total assets of ¥2.28 billion and total common equity of ¥214.51 million.
The expected completion of the transaction is December 26, 2025. Buy Or Sell Opportunity • Dec 04
Now 21% overvalued Over the last 90 days, the stock has fallen 2.4% to JP¥2,159. The fair value is estimated to be JP¥1,782, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.4% over the last 3 years. Earnings per share has declined by 48%. Reported Earnings • Nov 15
Third quarter 2025 earnings released: EPS: JP¥23.99 (vs JP¥8.57 loss in 3Q 2024) Third quarter 2025 results: EPS: JP¥23.99 (up from JP¥8.57 loss in 3Q 2024). Revenue: JP¥1.75b (up 47% from 3Q 2024). Net income: JP¥106.0m (up JP¥120.0m from 3Q 2024). Profit margin: 6.1% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Announcement • Sep 17
GMO Research & AI, Inc. to Report Q3, 2025 Results on Nov 12, 2025 GMO Research & AI, Inc. announced that they will report Q3, 2025 results on Nov 12, 2025 Reported Earnings • Aug 08
Second quarter 2025 earnings released: EPS: JP¥12.67 (vs JP¥12.24 loss in 2Q 2024) Second quarter 2025 results: EPS: JP¥12.67 (up from JP¥12.24 loss in 2Q 2024). Revenue: JP¥1.85b (up 68% from 2Q 2024). Net income: JP¥56.0m (up JP¥76.0m from 2Q 2024). Profit margin: 3.0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings. Announcement • Jun 27
GMO Research & AI, Inc. to Report Q2, 2025 Results on Aug 07, 2025 GMO Research & AI, Inc. announced that they will report Q2, 2025 results on Aug 07, 2025 New Risk • May 17
New major risk - Revenue and earnings growth Earnings have declined by 0.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 7x earnings per share. Cash payout ratio: 447% Earnings have declined by 0.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (0.5% net profit margin). Market cap is less than US$100m (JP¥11.1b market cap, or US$76.0m). Reported Earnings • May 17
First quarter 2025 earnings released: JP¥41.01 loss per share (vs JP¥56.35 profit in 1Q 2024) First quarter 2025 results: JP¥41.01 loss per share (down from JP¥56.35 profit in 1Q 2024). Revenue: JP¥1.32b (down 3.2% from 1Q 2024). Net loss: JP¥67.0m (down 173% from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 15
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to JP¥2,374, the stock trades at a trailing P/E ratio of 57.1x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 4.5% over the past three years. New Risk • Apr 18
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 169% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 103% Cash payout ratio: 447% Shareholders have been substantially diluted in the past year (169% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥12.2b market cap, or US$85.7m). Announcement • Mar 08
GMO Research & AI, Inc. to Report Q1, 2025 Results on May 12, 2025 GMO Research & AI, Inc. announced that they will report Q1, 2025 results on May 12, 2025 New Risk • Feb 15
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Dividend yield: 4.1% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 127% Cash payout ratio: 166% Minor Risks Profit margins are more than 30% lower than last year (3.6% net profit margin). Market cap is less than US$100m (JP¥4.57b market cap, or US$30.0m). Reported Earnings • Feb 14
Full year 2024 earnings released: EPS: JP¥112 (vs JP¥188 in FY 2023) Full year 2024 results: EPS: JP¥112 (down from JP¥188 in FY 2023). Revenue: JP¥5.03b (down 1.8% from FY 2023). Net income: JP¥183.0m (down 40% from FY 2023). Profit margin: 3.6% (down from 6.0% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. New Risk • Feb 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (127% payout ratio). Share price has been volatile over the past 3 months (7.5% average weekly change). Profit margins are more than 30% lower than last year (3.0% net profit margin). Market cap is less than US$100m (JP¥4.69b market cap, or US$30.5m). Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to JP¥2,870, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 17x in the Media industry in Japan. Total returns to shareholders of 38% over the past three years. Announcement • Feb 12
GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025 GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025. Upcoming Dividend • Dec 20
Upcoming dividend of JP¥115 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 24 March 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.3%). Announcement • Dec 14
GMO Research & AI, Inc. to Report Fiscal Year 2024 Results on Feb 12, 2025 GMO Research & AI, Inc. announced that they will report fiscal year 2024 results on Feb 12, 2025 Reported Earnings • Nov 08
Third quarter 2024 earnings released: JP¥8.57 loss per share (vs JP¥38.59 profit in 3Q 2023) Third quarter 2024 results: JP¥8.57 loss per share (down from JP¥38.59 profit in 3Q 2023). Revenue: JP¥1.19b (down 2.3% from 3Q 2023). Net loss: JP¥14.0m (down 122% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Announcement • Sep 27
GMO Research & AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024 GMO Research & AI, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024 Reported Earnings • Aug 09
Second quarter 2024 earnings released: JP¥12.24 loss per share (vs JP¥11.64 profit in 2Q 2023) Second quarter 2024 results: JP¥12.24 loss per share (down from JP¥11.64 profit in 2Q 2023). Revenue: JP¥1.10b (down 4.3% from 2Q 2023). Net loss: JP¥20.0m (down 205% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to JP¥2,258, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 16x in the Media industry in Japan. Total returns to shareholders of 7.6% over the past three years. Announcement • Jun 28
GMO Research & AI, Inc. to Report Q2, 2024 Results on Aug 06, 2024 GMO Research & AI, Inc. announced that they will report Q2, 2024 results on Aug 06, 2024 Reported Earnings • May 09
First quarter 2024 earnings released: EPS: JP¥56.31 (vs JP¥82.69 in 1Q 2023) First quarter 2024 results: EPS: JP¥56.31 (down from JP¥82.69 in 1Q 2023). Revenue: JP¥1.36b (down 4.6% from 1Q 2023). Net income: JP¥92.0m (down 32% from 1Q 2023). Profit margin: 6.8% (down from 9.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Announcement • Mar 17
GMO Research, Inc. to Report Q1, 2024 Results on May 08, 2024 GMO Research, Inc. announced that they will report Q1, 2024 results on May 08, 2024 Reported Earnings • Feb 07
Full year 2023 earnings released: EPS: JP¥188 (vs JP¥218 in FY 2022) Full year 2023 results: EPS: JP¥188 (down from JP¥218 in FY 2022). Revenue: JP¥5.12b (down 1.6% from FY 2022). Net income: JP¥307.0m (down 14% from FY 2022). Profit margin: 6.0% (down from 6.8% in FY 2022). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 07
GMO Research, Inc., Annual General Meeting, Mar 18, 2024 GMO Research, Inc., Annual General Meeting, Mar 18, 2024. Announcement • Dec 28
GMO Research, Inc. to Report Fiscal Year 2023 Results on Feb 05, 2024 GMO Research, Inc. announced that they will report fiscal year 2023 results on Feb 05, 2024 Upcoming Dividend • Dec 21
Upcoming dividend of JP¥115 per share at 4.0% yield Eligible shareholders must have bought the stock before 28 December 2023. Payment date: 25 March 2024. Payout ratio is a comfortable 70% but the company is not cash flow positive. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (2.7%). Reported Earnings • Nov 07
Third quarter 2023 earnings released: EPS: JP¥38.59 (vs JP¥44.12 in 3Q 2022) Third quarter 2023 results: EPS: JP¥38.59 (down from JP¥44.12 in 3Q 2022). Revenue: JP¥1.22b (flat on 3Q 2022). Net income: JP¥63.0m (down 13% from 3Q 2022). Profit margin: 5.2% (down from 5.9% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 15% per year and the company’s share price has also increased by 15% per year. Announcement • Sep 17
GMO Research, Inc. to Report Q3, 2023 Results on Nov 06, 2023 GMO Research, Inc. announced that they will report Q3, 2023 results on Nov 06, 2023 New Risk • Aug 14
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 52% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (52% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.59b market cap, or US$31.7m). New Risk • Aug 05
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.0% Last year net profit margin: 8.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (469% cash payout ratio). Profit margins are more than 30% lower than last year (5.0% net profit margin). Market cap is less than US$100m (JP¥4.83b market cap, or US$34.1m). Reported Earnings • Aug 04
Second quarter 2023 earnings released: EPS: JP¥11.64 (vs JP¥43.51 in 2Q 2022) Second quarter 2023 results: EPS: JP¥11.64 (down from JP¥43.51 in 2Q 2022). Revenue: JP¥1.15b (down 2.7% from 2Q 2022). Net income: JP¥19.0m (down 73% from 2Q 2022). Profit margin: 1.6% (down from 6.0% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 21% per year. Announcement • Jun 28
GMO Research, Inc. to Report Q2, 2023 Results on Aug 03, 2023 GMO Research, Inc. announced that they will report Q2, 2023 results on Aug 03, 2023 Reported Earnings • May 10
First quarter 2023 earnings released: EPS: JP¥82.69 (vs JP¥107 in 1Q 2022) First quarter 2023 results: EPS: JP¥82.69 (down from JP¥107 in 1Q 2022). Revenue: JP¥1.43b (up 4.5% from 1Q 2022). Net income: JP¥135.0m (down 23% from 1Q 2022). Profit margin: 9.5% (down from 13% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year whereas the company’s share price has increased by 31% per year. Reported Earnings • Mar 28
Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021) Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year whereas the company’s share price has increased by 45% per year. Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to JP¥3,060, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 121% over the past three years. Reported Earnings • Feb 12
Full year 2022 earnings released: EPS: JP¥218 (vs JP¥168 in FY 2021) Full year 2022 results: EPS: JP¥218 (up from JP¥168 in FY 2021). Revenue: JP¥5.20b (up 27% from FY 2021). Net income: JP¥356.0m (up 30% from FY 2021). Profit margin: 6.8% (up from 6.7% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth. Announcement • Feb 08
GMO Research, Inc., Annual General Meeting, Mar 22, 2023 GMO Research, Inc., Annual General Meeting, Mar 22, 2023. Upcoming Dividend • Dec 22
Upcoming dividend of JP¥116 per share Eligible shareholders must have bought the stock before 29 December 2022. Payment date: 22 March 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.7%). Announcement • Dec 17
GMO Research, Inc. to Report Fiscal Year 2022 Results on Feb 06, 2023 GMO Research, Inc. announced that they will report fiscal year 2022 results on Feb 06, 2023 Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Nov 09
Third quarter 2022 earnings released: EPS: JP¥44.12 (vs JP¥28.82 in 3Q 2021) Third quarter 2022 results: EPS: JP¥44.12 (up from JP¥28.82 in 3Q 2021). Revenue: JP¥1.22b (up 22% from 3Q 2021). Net income: JP¥72.0m (up 53% from 3Q 2021). Profit margin: 5.9% (up from 4.7% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Announcement • Sep 18
GMO Research, Inc. to Report Q3, 2022 Results on Nov 07, 2022 GMO Research, Inc. announced that they will report Q3, 2022 results on Nov 07, 2022 Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment deteriorated over the past week After last week's 17% share price decline to JP¥3,740, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 15x in the Media industry in Japan. Total returns to shareholders of 116% over the past three years. Reported Earnings • Aug 05
Second quarter 2022 earnings released: EPS: JP¥43.51 (vs JP¥14.11 in 2Q 2021) Second quarter 2022 results: EPS: JP¥43.51 (up from JP¥14.11 in 2Q 2021). Revenue: JP¥1.19b (up 33% from 2Q 2021). Net income: JP¥71.0m (up 209% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Announcement • Jun 29
GMO Research, Inc. to Report Q2, 2022 Results on Aug 04, 2022 GMO Research, Inc. announced that they will report Q2, 2022 results on Aug 04, 2022 Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment improved over the past week After last week's 22% share price gain to JP¥4,080, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 13x in the Media industry in Japan. Total returns to shareholders of 148% over the past three years. Valuation Update With 7 Day Price Move • May 30
Investor sentiment improved over the past week After last week's 21% share price gain to JP¥3,095, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Media industry in Japan. Total returns to shareholders of 109% over the past three years. Announcement • May 12
GMO Research, Inc. to Report Q1, 2022 Results on May 09, 2022 GMO Research, Inc. announced that they will report Q1, 2022 results on May 09, 2022 Reported Earnings • May 11
First quarter 2022 earnings released: EPS: JP¥107 (vs JP¥64.39 in 1Q 2021) First quarter 2022 results: EPS: JP¥107 (up from JP¥64.39 in 1Q 2021). Revenue: JP¥1.37b (up 40% from 1Q 2021). Net income: JP¥175.0m (up 67% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. No independent directors (8 non-independent directors). Director Masashi Yasuda was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Feb 09
GMO Research, Inc., Annual General Meeting, Mar 18, 2022 GMO Research, Inc., Annual General Meeting, Mar 18, 2022. Reported Earnings • Feb 08
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: JP¥168 (up from JP¥107 in FY 2020). Revenue: JP¥4.09b (up 20% from FY 2020). Net income: JP¥274.0m (up 57% from FY 2020). Profit margin: 6.7% (up from 5.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Dec 22
Upcoming dividend of JP¥73.53 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 22 March 2022. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.9%). Reported Earnings • Nov 10
Third quarter 2021 earnings released: EPS JP¥28.82 (vs JP¥25.76 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥999.0m (up 27% from 3Q 2020). Net income: JP¥47.0m (up 12% from 3Q 2020). Profit margin: 4.7% (down from 5.3% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 18% share price gain to JP¥2,603, the stock trades at a trailing P/E ratio of 17x. Average trailing P/E is 24x in the Media industry in Japan. Total returns to shareholders of 66% over the past three years. Reported Earnings • May 08
First quarter 2021 earnings released: EPS JP¥64.39 (vs JP¥19.01 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: JP¥976.0m (up 6.7% from 1Q 2020). Net income: JP¥105.0m (up 239% from 1Q 2020). Profit margin: 11% (up from 3.4% in 1Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 07
Investor sentiment improved over the past week After last week's 15% share price gain to JP¥2,050, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 23x in the Media industry in Japan. Total returns to shareholders of 18% over the past three years. Announcement • Apr 29
GMO Research, Inc. to launch new service brand “MO Lite” GMO Research, Inc. has rolled out a new initiative to support companies in conducting online research projects with the fastest and most cost-effective turnaround in APAC. There is an increasing demand for DIY market research tools that allow companies to conduct survey research remotely and at low costs. But when a company really starts to plan a research project, there are some common obstacles. Firstly, the targeted audience is limited to the company’s own service and/or product line, so the company cannot collect a larger number of responses. Secondly, recruiting people for a survey is a time-consuming and costly process. And lastly, localizing questionnaires, ensuring they align with local law, and checking that the contents address the cultural and linguistic background correctly takes a great deal of effort. To address these issues, GMO Research has developed “MO Lite”, a new service that enables companies to link their own using DIY market research tools to recruit survey respondents directly from one of the largest pool of panelists in APAC, with a price less as USD 10 cent per question, that comes with full support from APAC local experts. USD 300 minimum fee will be included. Announcement • Feb 11
GMO Research, Inc., Annual General Meeting, Mar 19, 2021 GMO Research, Inc., Annual General Meeting, Mar 19, 2021. Reported Earnings • Feb 11
Full year 2020 earnings released: EPS JP¥107 (vs JP¥83.74 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: JP¥3.39b (up 3.2% from FY 2019). Net income: JP¥175.0m (up 28% from FY 2019). Profit margin: 5.2% (up from 4.2% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 1% per year. Is New 90 Day High Low • Dec 29
New 90-day low: JP¥1,645 The company is down 3.0% from its price of JP¥1,702 on 30 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 2.0% over the same period. Announcement • Oct 04
GMO Research, Inc. to Report Q3, 2020 Results on Nov 06, 2020 GMO Research, Inc. announced that they will report Q3, 2020 results on Nov 06, 2020 Announcement • Jun 28
GMO Research, Inc. to Report Q2, 2020 Results on Aug 07, 2020 GMO Research, Inc. announced that they will report Q2, 2020 results on Aug 07, 2020